Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial | MicrobiomeTrials← Back to trialsNCT07650656
Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2027-05-15Est. Completion: 2028-05-11
Enrollment target: 22 participants Locations- City of Hope Medical Center, Duarte, California, United States
Other microbiome trials you might be interested in
Soft Tissue Sarcomas
This is a single center, single arm phase I clinical trial exploring the feasibility and safety of performing transarter…
Multiple LocationsCompleted Feb 2028
KSHV Inflammatory Cytokine Syndrome (KICS)KSHVHHV-8
Background:
\- KSHV inflammatory cytokine syndrome (KICS) is a newly recognized disease caused by Kaposi sarcoma-associ…
Bethesda, United StatesEst. completion Dec 31, 2028